We are live on ! Find out more
NRD

Nebula Research & Development Portfolio holdings

AUM $1.17B
1-Year Est. Return 15.19%
This Fund
S&P 500
This Quarter Est. Return
+7.19%
1 Year Est. Return
+15.19%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$836M
AUM Growth
+$219M
Cap. Flow
+$188M
Cap. Flow %
22.5%
Top 10 Hldgs %
4.49%
Holding
1,220
New
441
Increased
247
Reduced
213
Closed
319

Top Buys

Rank Stock Value
1
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$4.41M
2
AAP icon
Advance Auto Parts
AAP
+$4.15M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$3.96M
4
DLTR icon
Dollar Tree
DLTR
+$3.82M
5
MSFT icon
Microsoft
MSFT
+$3.74M

Top Sells

Rank Stock Value
1
BAC icon
Bank of America
BAC
+$2.82M
2
KO icon
Coca-Cola
KO
+$2.82M
3
GD icon
General Dynamics
GD
+$2.82M
4
ORCL icon
Oracle
ORCL
+$2.81M
5
HLNE icon
Hamilton Lane
HLNE
+$2.8M

Sector Composition

Rank Sector Weight
1 Technology 16.51%
2 Industrials 15.72%
3 Consumer Discretionary 15.68%
4 Healthcare 13.43%
5 Financials 10.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MOV icon
476
Movado Group
MOV
$846M
$627K 0.08%
33,719
+14,298
+74% +$329K
ACT icon
477
Enact Holdings
ACT
$6.7B
$627K 0.08%
17,254
-8,964
-34% -$306K
DX
478
Dynex Capital
DX
$3.07B
$623K 0.07%
48,842
-37,599
-43% -$464K
SUI icon
479
Sun Communities
SUI
$15.3B
$618K 0.07%
+4,573
New +$601K
BUR icon
480
Burford Capital
BUR
$955M
$615K 0.07%
46,397
-16,031
-26% -$213K
MSA icon
481
Mine Safety
MSA
$6.94B
$610K 0.07%
+3,441
New +$626K
CTO
482
CTO Realty Growth
CTO
$740M
$608K 0.07%
+31,992
New +$608K
MSGS icon
483
Madison Square Garden
MSGS
$9.58B
$607K 0.07%
+2,913
New +$586K
ZEUS
484
DELISTED
Olympic Steel
ZEUS
$606K 0.07%
+15,537
New +$653K
GNTX icon
485
Gentex
GNTX
$5.12B
$605K 0.07%
20,378
-1,541
-7% -$47.9K
PLTK icon
486
Playtika
PLTK
$1.51B
$604K 0.07%
76,307
-50,465
-40% -$379K
BPMC
487
DELISTED
Blueprint Medicines
BPMC
$604K 0.07%
+6,529
New +$649K
AVY icon
488
Avery Dennison
AVY
$12.9B
$599K 0.07%
+2,713
New +$586K
CVX icon
489
Chevron
CVX
$374B
$595K 0.07%
+4,043
New +$602K
LVS icon
490
Las Vegas Sands
LVS
$32B
$588K 0.07%
+11,682
New +$479K
BRK.B icon
491
Berkshire Hathaway Class B
BRK.B
$1.11T
$587K 0.07%
1,276
-552
-30% -$244K
LSTR icon
492
Landstar System
LSTR
$6.29B
$587K 0.07%
3,109
+1,737
+127% +$320K
MTX icon
493
Minerals Technologies
MTX
$2.33B
$587K 0.07%
7,601
+1,970
+35% +$152K
UAA icon
494
Under Armour
UAA
$3.04B
$584K 0.07%
+65,534
New +$487K
MEI icon
495
Methode Electronics
MEI
$525M
$582K 0.07%
48,690
-16,979
-26% -$190K
TARS icon
496
Tarsus Pharmaceuticals
TARS
$2.57B
$582K 0.07%
+17,684
New +$497K
BKE icon
497
Buckle
BKE
$2.35B
$580K 0.07%
+13,183
New +$541K
OXM icon
498
Oxford Industries
OXM
$613M
$578K 0.07%
6,666
+562
+9% +$51.7K
CGEM icon
499
Cullinan Oncology
CGEM
$1.07B
$578K 0.07%
34,537
+21,412
+163% +$380K
FIX icon
500
Comfort Systems
FIX
$57.2B
$574K 0.07%
+1,470
New +$484K
18 19
20
21 22

Similar funds

SAF
Smith Anglin Financial Dallas, Texas $1.1B AUM 14.08% 1-Year Est. Return
GIM
Grassi Investment Management Santa Clara, California $1.26B AUM 23.4% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
PP
PrairieView Partners St. Paul, Minnesota $1.03B AUM 11.4% 1-Year Est. Return
FC
Forte Capital Rochester, New York $930M AUM 24.11% 1-Year Est. Return
HIP
HPS Investment Partners New York $1.52B AUM 19.81% 1-Year Est. Return
SC
Savoie Capital Chicago, Illinois $805M AUM 19.48% 1-Year Est. Return
BWA
Bordeaux Wealth Advisors Menlo Park, California $781M AUM 26.55% 1-Year Est. Return

Nebula Research & Development's Q3 2024 Portfolio in Review

As of Q3 2024, Nebula Research & Development held 1,220 positions worth $836M, up 35% from $618M the previous quarter. Its ten largest holdings account for 4.5% of the portfolio.

Nebula Research & Development deployed $188M of net new capital in Q3 2024, opening 441 new positions and adding to 247 existing holdings. Its largest new stake was BioMarin Pharmaceuticals: 52,699 shares worth $3.7M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Travelers Companies, an estimated $2.39M trimmed.

  • Nebula Research & Development's largest Q3 2024 buy was BioMarin Pharmaceuticals: 52,699 shares worth $3.7M.
  • Nebula Research & Development added most to Dollar Tree in Q3 2024, an estimated $3.82M increase.
  • Nebula Research & Development's biggest Q3 2024 reduction was Travelers Companies, cutting an estimated $2.39M.
  • Nebula Research & Development fully exited Bank of America in Q3 2024, selling an estimated $2.82M.
  • Nebula Research & Development's ten largest holdings make up 4.5% of its $836M portfolio in Q3 2024.
  • Nebula Research & Development opened 441 new positions and closed 319 in Q3 2024.
  • Nebula Research & Development's portfolio value rose 35% quarter-over-quarter to $836M.

Based on Nebula Research & Development's 13F filing for Q3 2024, filed 14 Nov 2024.